Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Shire PLC (NASDAQ:SHPG)

193.86
Delayed Data
As of Sep 30
 -0.96 / -0.49%
Today’s Change
147.60
Today|||52-Week Range
231.32
-5.43%
Year-to-Date
Third Value Fund Avenue Buys 3 Stocks in 3rd Quarter
Sep 28 / GuruFocus News - Paid Partner Content
Whitman's Third Avenue Buys 3 Pharma Stocks in 3rd Quarter
Sep 27 / GuruFocus News - Paid Partner Content
Momenta to Regain Rights to Humira Biosimilar from Shire
Sep 28 / Zacks.com - Paid Partner Content
Mairs and Power Buys Walt Disney, Exits Baxalta
Sep 27 / GuruFocus News - Paid Partner Content

Today’s Trading

Previous close194.82
Today’s open195.03
Day’s range193.23 - 195.27
Volume1,427,270
Average volume (3 months)1,928,754
Market cap$58.3B
Dividend yield0.41%
Data as of 3:59pm ET, 09/30/2016

Growth & Valuation

Earnings growth (last year)-61.89%
Earnings growth (this year)+10.31%
Earnings growth (next 5 years)+13.91%
Revenue growth (last year)+6.79%
P/E ratio31.4
Price/Sales6.33
Price/Book3.89

Competitors

 Today’s
change
Today’s
% change
ABTAbbott Laboratories+0.85+2.05%
REGNRegeneron Pharmaceut...-4.34-1.07%
CELGCelgene+1.76+1.71%
NVONovo Nordisk-0.21-0.50%
Data as of 4:14pm ET, 09/30/2016

Financials

Next reporting dateOctober 28, 2016
EPS forecast (this quarter)$3.25
Annual revenue (last year)$6.4B
Annual profit (last year)$1.3B
Net profit margin20.84%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chief Executive Officer &
Executive Director
Flemming Ornskov
Chief Financial Officer &
Executive Director
Jeffrey Poulton
Corporate headquarters
Dublin, Dublin

Forecasts

Search for Jobs